Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitals
- 1 June 2020
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 55 (6) , 105970
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Carbapenem use in critically ill patientsCurrent Opinion in Infectious Diseases, 2020
- Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research NetworkAntimicrobial Agents and Chemotherapy, 2019
- Evaluation of carbapenem use in a tertiary hospital: antimicrobial stewardship urgently neededAntimicrobial Resistance & Infection Control, 2019
- Antimicrobial consumption in five adult intensive care units: a 33-month surveillance studyAntimicrobial Resistance & Infection Control, 2018
- Infections Caused by Resistant Gram‐Negative Bacteria: Epidemiology and ManagementPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic StewardshipClinical Infectious Diseases, 2009
- Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2009